Junshi Bio (HKEX: 1877, SSE: 688180) Announces Share Reduction Results of Major Shareholder

Bulletin Express

2025/12/04

Shanghai Junshi Biosciences Co., Ltd. disclosed that Shanghai Tanying Investment Partnership (LP), previously holding 71,459,326 A shares (6.9602% of total share capital), completed a shareholding reduction plan within the authorized timeframe from 5 September 2025 to 4 December 2025. According to the official announcement, Shanghai Tanying sold 12,000,000 A shares via block trading, representing approximately 1.1688% of the total share capital.

Following the transaction, Shanghai Tanying now holds 59,459,326 A shares, which constitutes about 5.7914% of the total share capital. This shareholding reduction was prompted by fund maturity and liquidity arrangements, and aligned with disclosures previously made in August 2025. The plan’s execution has concluded, and no further reductions are indicated.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1198166631"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1198166631\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1198166631?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-04 19:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1198166631","market":"hk","top_or_hot":-1,"title":"Junshi Bio (HKEX: 1877, SSE: 688180) Announces Share Reduction Results of Major Shareholder","media":"Bulletin Express","content":"<p>Shanghai Junshi Biosciences Co., Ltd. disclosed that Shanghai Tanying Investment Partnership (LP), previously holding 71,459,326 A shares (6.9602% of total share capital), completed a shareholding reduction plan within the authorized timeframe from 5 September 2025 to 4 December 2025. According to the official announcement, Shanghai Tanying sold 12,000,000 A shares via block trading, representing approximately 1.1688% of the total share capital.</p>\n<p>Following the transaction, Shanghai Tanying now holds 59,459,326 A shares, which constitutes about 5.7914% of the total share capital. This shareholding reduction was prompted by fund maturity and liquidity arrangements, and aligned with disclosures previously made in August 2025. The plan’s execution has concluded, and no further reductions are indicated.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Junshi Bio (HKEX: 1877, SSE: 688180) Announces Share Reduction Results of Major Shareholder</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJunshi Bio (HKEX: 1877, SSE: 688180) Announces Share Reduction Results of Major Shareholder\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2025-12-04 19:45</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Shanghai Junshi Biosciences Co., Ltd. disclosed that Shanghai Tanying Investment Partnership (LP), previously holding 71,459,326 A shares (6.9602% of total share capital), completed a shareholding reduction plan within the authorized timeframe from 5 September 2025 to 4 December 2025. According to the official announcement, Shanghai Tanying sold 12,000,000 A shares via block trading, representing approximately 1.1688% of the total share capital.</p>\n<p>Following the transaction, Shanghai Tanying now holds 59,459,326 A shares, which constitutes about 5.7914% of the total share capital. This shareholding reduction was prompted by fund maturity and liquidity arrangements, and aligned with disclosures previously made in August 2025. The plan’s execution has concluded, and no further reductions are indicated.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01877","symbol_name":"君實生物","start_time":0,"source_url":"","article_id":"1198166631","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1198166631","pubTimestamp":1764848749,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Junshi Biosciences Co., Ltd. disclosed that Shanghai Tanying Investment Partnership (LP), previously holding 71,459,326 A shares (6.9602% of total share capital), completed a shareholding...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01877":"君实生物"},"translate_title":"君实生物（港交所：1877，上交所：688180）公布大股东减持股份结果","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01877":1},"content_text":"Shanghai Junshi Biosciences Co., Ltd. disclosed that Shanghai Tanying Investment Partnership (LP), previously holding 71,459,326 A shares (6.9602% of total share capital), completed a shareholding reduction plan within the authorized timeframe from 5 September 2025 to 4 December 2025. According to the official announcement, Shanghai Tanying sold 12,000,000 A shares via block trading, representing approximately 1.1688% of the total share capital.\nFollowing the transaction, Shanghai Tanying now holds 59,459,326 A shares, which constitutes about 5.7914% of the total share capital. This shareholding reduction was prompted by fund maturity and liquidity arrangements, and aligned with disclosures previously made in August 2025. The plan’s execution has concluded, and no further reductions are indicated.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}